Results 221 to 230 of about 29,309,204 (245)
Some of the next articles are maybe not open access.

HDL Function and Atherosclerosis: Reactive Dicarbonyls as Promising Targets of Therapy

Circulation Research, 2023
Tao Huan   +2 more
exaly  

[Association between serum non-HDL-C and cardiovascular disease mortality risk].

Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]
To analyze the relationship between serum non-HDL-C levels and cardiovascular disease (CVD) mortality in community populations. A retrospective cohort study was conducted using the Yuecheng District Health Information Platform in Shaoxing City, Zhejiang Province.
B C, Dong   +9 more
openaire   +1 more source

The Advantages of Using Non–HDL-C in the Diagnosis and Treatment of Dyslipidemia—Reply

Archives of Internal Medicine, 2002
Yadong Cui   +3 more
openaire   +1 more source

NON-HDL-C: THE MISSING PARAMETER IN HYPERTENSION ASSESSMENT

Journal of Hypertension
Carlos Baeza   +5 more
openaire   +1 more source

non-HDL-C: The missing parameter in primary care

European Journal of Internal Medicine
Carlos Baeza-Delgado   +7 more
openaire   +1 more source

HDL and cancer - causality still needs to be confirmed? Update 2020

Seminars in Cancer Biology, 2021
Matteo Pirro, Shiva Ganjali
exaly  

High TG to HDL ratio plays a significant role on atherosclerosis extension in prediabetes and newly diagnosed type 2 diabetes subjects

Diabetes/Metabolism Research and Reviews, 2021
Philippe Cluzel   +2 more
exaly  

HDL-related biomarkers are robust predictors of survival in patients with chronic liver failure

Journal of Hepatology, 2020
Carlo Alessandria   +2 more
exaly  

Home - About - Disclaimer - Privacy